Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 9 - Number 8





Wealth of Opportunity - The C1 Domain as a Target for Drug Development

, 9(8): 641 - 652

P. M. Blumberg, N. Kedei, N. E. Lewin, D. Yang, G. Czifra, Y. Pu, M. L. Peach and V .E. Marquez


DOI: 10.2174/138945008785132376


Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy

, 9(8): 653 - 661

Youssef H. Zeidan, Russell W. Jenkins, John B. Korman, Xiang Liu, Lina M. Obeid, James S. Norris and Yusuf A. Hannun


DOI: 10.2174/138945008785132358


Targeting SphK1 as a New Strategy against Cancer

, 9(8): 662 - 673

Dai Shida, Kazuaki Takabe, Dmitri Kapitonov, Sheldon Milstien and Sarah Spiegel


DOI: 10.2174/138945008785132402







Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 5.5

Related Journals

Related eBooks

eBooks Catalog